GENEDX HOLDINGS CORP (WGS) Fundamental Analysis & Valuation
NASDAQ:WGS • US81663L2007
Current stock price
69.84 USD
-3.16 (-4.33%)
At close:
69.84 USD
0 (0%)
After Hours:
This WGS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. WGS Profitability Analysis
1.1 Basic Checks
- WGS had positive earnings in the past year.
- In the past year WGS had a positive cash flow from operations.
- In the past 5 years WGS always reported negative net income.
- WGS had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of WGS (-4.01%) is worse than 64.36% of its industry peers.
- WGS has a Return On Equity of -6.82%. This is comparable to the rest of the industry: WGS outperforms 43.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.01% | ||
| ROE | -6.82% | ||
| ROIC | N/A |
ROA(3y)-19.48%
ROA(5y)-42.92%
ROE(3y)-35.08%
ROE(5y)-76.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 69.74%, WGS belongs to the best of the industry, outperforming 87.13% of the companies in the same industry.
- The Profit Margin and Operating Margin are not available for WGS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.74% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. WGS Health Analysis
2.1 Basic Checks
- WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, WGS has more shares outstanding
- WGS has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, WGS has an improved debt to assets ratio.
2.2 Solvency
- WGS has an Altman-Z score of 3.38. This indicates that WGS is financially healthy and has little risk of bankruptcy at the moment.
- WGS's Altman-Z score of 3.38 is fine compared to the rest of the industry. WGS outperforms 71.29% of its industry peers.
- WGS has a debt to FCF ratio of 4.94. This is a neutral value as WGS would need 4.94 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 4.94, WGS is in the better half of the industry, outperforming 64.36% of the companies in the same industry.
- WGS has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
- WGS has a Debt to Equity ratio of 0.21. This is in the better half of the industry: WGS outperforms 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 4.94 | ||
| Altman-Z | 3.38 |
ROIC/WACCN/A
WACC8.83%
2.3 Liquidity
- A Current Ratio of 2.46 indicates that WGS has no problem at all paying its short term obligations.
- WGS has a better Current ratio (2.46) than 82.18% of its industry peers.
- A Quick Ratio of 2.34 indicates that WGS has no problem at all paying its short term obligations.
- With an excellent Quick ratio value of 2.34, WGS belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.46 | ||
| Quick Ratio | 2.34 |
3. WGS Growth Analysis
3.1 Past
- WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 508.70%, which is quite impressive.
- The Revenue has grown by 39.97% in the past year. This is a very strong growth!
- WGS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.98% yearly.
EPS 1Y (TTM)508.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.42%
Revenue 1Y (TTM)39.97%
Revenue growth 3Y22.13%
Revenue growth 5Y18.98%
Sales Q2Q%26.5%
3.2 Future
- WGS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.59% yearly.
- WGS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.38% yearly.
EPS Next Y-49.86%
EPS Next 2Y23.21%
EPS Next 3Y32.99%
EPS Next 5Y44.59%
Revenue Next Year28.89%
Revenue Next 2Y26.85%
Revenue Next 3Y25.54%
Revenue Next 5Y26.38%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. WGS Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 49.89, which means the current valuation is very expensive for WGS.
- The rest of the industry has a similar Price/Earnings ratio as WGS.
- The average S&P500 Price/Earnings ratio is at 25.73. WGS is valued rather expensively when compared to this.
- With a Price/Forward Earnings ratio of 99.49, WGS can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of WGS indicates a slightly more expensive valuation: WGS is more expensive than 60.40% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of WGS to the average of the S&P500 Index (23.72), we can say WGS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.89 | ||
| Fwd PE | 99.49 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WGS indicates a slightly more expensive valuation: WGS is more expensive than 68.32% of the companies listed in the same industry.
- WGS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. WGS is more expensive than 61.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 143.43 | ||
| EV/EBITDA | 162.27 |
4.3 Compensation for Growth
- WGS's earnings are expected to grow with 32.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.21%
EPS Next 3Y32.99%
5. WGS Dividend Analysis
5.1 Amount
- No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
WGS Fundamentals: All Metrics, Ratios and Statistics
69.84
-3.16 (-4.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23 2026-02-23/bmo
Earnings (Next)04-28 2026-04-28
Inst Owners106.79%
Inst Owner Change1.36%
Ins Owners1.51%
Ins Owner Change0.51%
Market Cap2.05B
Revenue(TTM)427.54M
Net Income(TTM)-21.02M
Analysts84.62
Price Target170 (143.41%)
Short Float %13.77%
Short Ratio4.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.56%
Min EPS beat(2)14.73%
Max EPS beat(2)24.4%
EPS beat(4)4
Avg EPS beat(4)197.35%
Min EPS beat(4)14.73%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)162.94%
EPS beat(12)10
Avg EPS beat(12)109.52%
EPS beat(16)12
Avg EPS beat(16)78.06%
Revenue beat(2)1
Avg Revenue beat(2)4.96%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)10.43%
Revenue beat(4)3
Avg Revenue beat(4)8.94%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)18.99%
Revenue beat(8)7
Avg Revenue beat(8)13.51%
Revenue beat(12)11
Avg Revenue beat(12)10.41%
Revenue beat(16)13
Avg Revenue beat(16)4.97%
PT rev (1m)-2.47%
PT rev (3m)3.59%
EPS NQ rev (1m)63.15%
EPS NQ rev (3m)74.07%
EPS NY rev (1m)24.85%
EPS NY rev (3m)31.13%
Revenue NQ rev (1m)-3.62%
Revenue NQ rev (3m)-3.3%
Revenue NY rev (1m)3.17%
Revenue NY rev (3m)4.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.89 | ||
| Fwd PE | 99.49 | ||
| P/S | 4.78 | ||
| P/FCF | 143.43 | ||
| P/OCF | 61.47 | ||
| P/B | 6.64 | ||
| P/tB | 16.21 | ||
| EV/EBITDA | 162.27 |
EPS(TTM)1.4
EY2%
EPS(NY)0.7
Fwd EY1.01%
FCF(TTM)0.49
FCFY0.7%
OCF(TTM)1.14
OCFY1.63%
SpS14.6
BVpS10.52
TBVpS4.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.01% | ||
| ROE | -6.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.74% | ||
| FCFM | 3.34% |
ROA(3y)-19.48%
ROA(5y)-42.92%
ROE(3y)-35.08%
ROE(5y)-76.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 4.94 | ||
| Debt/EBITDA | 5.39 | ||
| Cap/Depr | 75.39% | ||
| Cap/Sales | 4.45% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 273.97% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.46 | ||
| Quick Ratio | 2.34 | ||
| Altman-Z | 3.38 |
F-Score6
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)39.11%
Cap/Depr(5y)47.36%
Cap/Sales(3y)3.02%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)508.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.42%
EPS Next Y-49.86%
EPS Next 2Y23.21%
EPS Next 3Y32.99%
EPS Next 5Y44.59%
Revenue 1Y (TTM)39.97%
Revenue growth 3Y22.13%
Revenue growth 5Y18.98%
Sales Q2Q%26.5%
Revenue Next Year28.89%
Revenue Next 2Y26.85%
Revenue Next 3Y25.54%
Revenue Next 5Y26.38%
EBIT growth 1Y43.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-29.67%
EBIT Next 3Y42.98%
EBIT Next 5YN/A
FCF growth 1Y141.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.79%
OCF growth 3YN/A
OCF growth 5YN/A
GENEDX HOLDINGS CORP / WGS Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for GENEDX HOLDINGS CORP?
ChartMill assigns a fundamental rating of 4 / 10 to WGS.
What is the valuation status for WGS stock?
ChartMill assigns a valuation rating of 1 / 10 to GENEDX HOLDINGS CORP (WGS). This can be considered as Overvalued.
What is the profitability of WGS stock?
GENEDX HOLDINGS CORP (WGS) has a profitability rating of 2 / 10.
What is the valuation of GENEDX HOLDINGS CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for GENEDX HOLDINGS CORP (WGS) is 49.89 and the Price/Book (PB) ratio is 6.64.
What is the financial health of GENEDX HOLDINGS CORP (WGS) stock?
The financial health rating of GENEDX HOLDINGS CORP (WGS) is 7 / 10.